Director, Revenue Accounting & GTN (Biotech)

dynetherapeutics

Waltham (MA)

On-site

USD 200,000 - 230,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Dyne Therapeutics is seeking a Director of Revenue Accounting to lead the company’s revenue recognition function under US GAAP (ASC 606). The role partners with Commercial, FP&A, and external auditors to ensure accurate, timely revenue reporting during pre-commercial to multi-product commercialization.

The ideal candidate will have extensive biotech/pharma GTN experience, hands-on ASC 606 work, and a track record of implementing robust internal controls and accounting policies.”

Qualifications

  • Bachelor's degree in Accounting, Finance, or related field.
  • CPA certification required.
  • 10+ years of progressive accounting experience in biotech/pharma revenue accounting.
  • Big 4 public accounting background preferred.
  • Deep ASC 606 knowledge for pharmaceutical product sales.
  • Experience with rebates/GTN accounting in specialty pharma.
  • Experience with distributors and GPOs and channel data interpretation.

Responsibilities

  • Own end-to-end revenue recognition for product sales under ASC 606.
  • Lead monthly/quarterly close including journal entries and reconciliations.
  • Develop and maintain GTN estimation models (rebates, chargebacks, distribution fees, copays).
  • Maintain SOX-compliant internal controls over revenue and GTN accruals.
  • Collaborate with FP&A, Commercial Ops, and Supply Chain for forecasts and reporting.
  • Evaluate and implement systems/tools to automate revenue and GTN processes.

Skills

Revenue accounting
ASC 606
Cross-functional partnering
SOX controls
Financial analysis

Education

Bachelor's degree in Accounting/Finance
CPA

Tools

NetSuite
ERP systems

Job description

Dyne Therapeutics is seeking a Director of Revenue Accounting to lead the company’s revenue recognition function under US GAAP (ASC 606). The role partners with Commercial, FP&A, and external auditors to ensure accurate, timely revenue reporting during pre-commercial to multi-product commercialization.

The ideal candidate will have extensive biotech/pharma GTN experience, hands-on ASC 606 work, and a track record of implementing robust internal controls and accounting policies.”

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Director of Revenue Accounting & GTN
Director of Revenue Accounting & GTN

Dyne Therapeutics, Inc. • Waltham (MA)

Hybrid
USD 200,000 - 230,000
Director, Revenue
Director, Revenue

dynetherapeutics • Waltham (MA)

On-site
USD 200,000 - 230,000
Director, Revenue
Director, Revenue

Dyne Therapeutics, Inc. • Waltham (MA)

Hybrid
USD 200,000 - 230,000
Director, Revenue Accounting & GTN Strategy
Director, Revenue Accounting & GTN Strategy

Revolution Medicines, Inc. • United States

On-site
USD 201,000 - 251,000
Director, Revenue Accounting & GTN Strategy
Director, Revenue Accounting & GTN Strategy

revolutionmedicines • United States

On-site
USD 180,000 - 260,000
Revenue Accounting Lead — GTN & ASC 606
Revenue Accounting Lead — GTN & ASC 606

Apnimed • Cambridge (MA)

On-site
USD 170,000 - 182,000
401(k) with company match
Generous vacation
Generous healthcare benefits
+3
Director, Revenue Accounting (GTN) - Biotech
Director, Revenue Accounting (GTN) - Biotech

Mason & Blair, LLC • Palo Alto (CA)

Hybrid
USD 120,000 - 160,000
Director/Manager Revenue Accounting- GTN
Director/Manager Revenue Accounting- GTN

Mason & Blair, LLC • Palo Alto (CA)

Hybrid
USD 120,000 - 160,000
Associate Director, Revenue Accounting — GTN & Analytics
Associate Director, Revenue Accounting — GTN & Analytics

Teva Pharmaceuticals • Parsippany-Troy Hills (NJ)

Hybrid
USD 144,000 - 180,000
Hybrid work model
Director of Revenue Accounting & ASC 606 Lead
Director of Revenue Accounting & ASC 606 Lead

Fortrea • Durham (CA)

Hybrid
USD 150,000 - 210,000